HARVARD BIOSCIENCE, INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
HARVARD BIOSCIENCE, INC. (HBIO) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$2.62 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2019-11-08
- HARVARD BIOSCIENCE, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-09-30 was -$2.62M.
- HARVARD BIOSCIENCE, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-06-30 was -$247.00K.
- HARVARD BIOSCIENCE, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2019-03-31 was -$2.37M.
- HARVARD BIOSCIENCE, INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2018-09-30 was -$256.00K.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month |
|---|---|---|---|
| 2019-09-30 | -$2.62M 10-Q · filed 2019-11-08 | -$2.87M derived: sum of 2 quarters · filed 2019-11-08 | -$5.24M 10-Q · filed 2019-11-08 |
| 2019-06-30 | -$247.00K 10-Q · filed 2019-08-08 | -$2.62M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | -$2.37M 10-Q · filed 2019-05-08 | ||
| 2018-09-30 | -$256.00K 10-Q · filed 2019-11-08 | -$1.75M derived: sum of 2 quarters · filed 2019-11-08 | -$7.60M 10-Q · filed 2019-11-08 |
| 2018-06-30 | -$1.50M 10-Q · filed 2019-08-08 | -$7.35M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | -$5.85M 10-Q · filed 2019-05-08 | ||
| 2017-09-30 | -$645.00K 10-Q · filed 2018-11-01 | -$1.26M derived: sum of 2 quarters · filed 2018-11-01 | -$2.00M 10-Q · filed 2018-11-01 |
| 2017-06-30 | -$617.00K 10-Q · filed 2018-08-02 | -$1.36M 10-Q · filed 2018-08-02 | |
| 2017-03-31 | -$743.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |